Delivery Order SPE2DB20D3103-SPE2DB25FM8K9
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,482.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,614,795 units of 4 mg Ondansetron HCL tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
This federal contract award, valued at $19,223.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,816,308 units of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 2, 2025. It is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,254,788 tablets of 4 mg Ondansetron HCl, a medication used to prevent nausea and vomiting. The $12,053.89 firm fixed-price delivery order has a completion date of February 13, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $17,009.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,665,266 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 4, 2024. It is not designated as a...
This federal contract award, valued at $2,919.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, which are used to treat nausea and vomiting. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,984.18, is for the delivery of 4,567,343 units of 4 mg ondansetron hydrochloride tablets, a medication used to prevent nausea and vomiting. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $3,518.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,793,731 tablets of Ondansetron HCL 4 mg, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order, with a period of performance through June 4, 2024. This award is part of a larger Indefinite Delivery Contract...
This federal contract award, valued at $10,038.08, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,254,639 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $3,258.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,222,523 units of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $22,819.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,037,797 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism and an ultimate completion date of January 27, 2025. This contract award is not...